AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Norbert Vey, MD
Institut Paoli Calmettes, Marseille, France
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Institut Paoli Calmettes
Marseille, France
Not, yet, recruiting
- National and Kapodistrian University of Athens Nkua · Department of Hematology and Bone Marrow Transplantation Unit
Athens, Greece
Recruiting
- General University Hospital of Alicantet (hospital General Universitario Dr. Balmis de Alicante)
Alicante, Spain
Recruiting - Hospital San Pedro de Alcantara
Cáceres, Spain
Recruiting - Hospital Universitario 12 de Octubre
Madrid, Spain
Recruiting - Hospital Universitario Quirónsalud
Madrid, Spain
Recruiting - Md Anderson Cancer Center Madrid
Madrid, Spain
Recruiting - Clínica Universidad de Navarra
Pamplona, Spain
Recruiting - Virgen del Rocío University Hospital (hospital Universitario Virgen del Rocío)
Seville, Spain
Recruiting
- Md Anderson Cancer Center
Houston, Texas, United States
Not, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jun 2022
- Primary completion
- 31 Aug 2026
- Completion
- 31 Dec 2026
- Last update posted
- 2 Oct 2025
- Registered enrollment
- 78
- Registry id
- NCT05211570
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.